Study guide
9.7 Interprofessional Care Coordination for Sterile Preparations
BCSCP Board Certified Sterile Compounding Pharmacist Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview, USP Standards & CSP Categories
1.1 BCSCP Exam Format, Eligibility, Scoring & 2024 Content Outline 1.2 USP <797> Scope, Core Philosophy & Regulatory Framework 1.3 USP <797> Categories 1, 2, and 3 CSP Classification 1.4 Immediate-Use CSPs: The 4-Hour Rule and Its Conditions
2 Chapter 2: Facilities, Engineering Controls & Cleaning
2.1 Cleanroom Architecture & ISO Classifications 2.2 Primary Engineering Controls (PECs) & Laminar Airflow Dynamics 2.3 Segregated Compounding Areas (SCAs) & Containment SCAs (C-SCAs) 2.4 HVAC Engineering Controls, Pressure Differentials & Air Exchange 2.5 Equipment & Materials in Classified Areas Under Dynamic Conditions 2.6 Cleaning, Disinfecting, Sporicidal Agents & Sterile 70% IPA 2.7 Contingency Planning: Power, HVAC, Supply and Staffing Failures
3 Chapter 3: Environmental Monitoring & Facility Certification
3.1 Viable Airborne Microbial Monitoring 3.2 Total Airborne Non-Viable Particle Counting & Cleanroom Certification Standards 3.3 Surface Microbial Sampling: Contact Plates, Swabs, Incubation Protocols & Action Levels 3.4 Environmental Sampling Excursions, Trend Analysis, and Remediation Protocols
4 Chapter 4: Hand Hygiene, Garbing & Aseptic Technique
4.1 Hand Hygiene & Cleansing Protocols 4.2 Step-by-Step Garbing Sequence & Ante-Room Logistics 4.3 Direct Compounding Area (DCA) Aseptic Technique & First Air Integrity
5 Chapter 5: Beyond-Use Dating, Storage & Container Rules
5.1 Category 1 Beyond-Use Dating & Storage Limitations 5.2 Category 2 Beyond-Use Dating: Sterile vs. Nonsterile Starting Components 5.3 Category 3 Beyond-Use Dating: Requirements for Extended Dating (60/90/120 Days) 5.4 Container Types, Puncture Limits & Multi-Dose Container Rules
6 Chapter 6: Sterilization, Release Testing & Hazardous Drug Compounding
6.1 Terminal Sterilization vs. Sterilizing Filtration 6.2 Release Testing: Sterility (USP <71>), Endotoxin (USP <85>) & Particulates (USP <788>) 6.3 Container Closure Integrity Testing (CCIT) & Visual Inspection 6.4 USP <800> Hazardous Drug Compounding & Closed System Drug-Transfer Devices (CSTDs)
7 Chapter 7: Materials, Equipment & Compounding Workflow
7.1 Compounding Equipment & Technology: ACDs, Balances, Pumps & IV Workflow Systems 7.2 Compounding Supplies, Containers & Closures 7.3 Component Receipt, Storage & Material Transfer 7.4 Calibration, Verification, Validation & Maintenance of Equipment 7.5 Compounding Workflow: SOPs, Workflow Software, Production Queues & Labeling 7.6 Handling, Storing, Packaging, Transporting & Disposing of Finished CSPs
8 Chapter 8: Calculations, Osmolarity & Physicochemical Compatibility
8.1 Sterile Compounding Calculations: Millimoles, Milliequivalents, Osmolarity & Tonicity Adjustments 8.2 Physical and Chemical Incompatibilities: pH Effects, Salt Formations & Precipitation Mechanisms 8.3 Complex Admixture Compatibility: Calcium-Phosphate Solubility Curves & Parenteral Nutrition Dynamics
9 Chapter 9: Therapeutics, Administration & Patient Monitoring
9.1 Patient-Specific Parameters: Verifying CSP Orders 9.2 Special Administration Routes: Epidural, Intrathecal, Ophthalmic & Intravesical Sterile Preparations 9.3 Medication Delivery Devices, Home Infusion & Patient Education 9.4 High-Alert Sterile Medications, Pediatric/Neonatal Considerations & Extravasation Management 9.5 Therapeutic Drug Monitoring, Catheter-Related Bloodstream Infection (CRBSI) Prevention & Clinical Vigilance 9.6 Medication Adherence in Home and Outpatient Sterile Therapy 9.7 Interprofessional Care Coordination for Sterile Preparations
10 Chapter 10: Quality Management, Records & Personnel Competency
10.1 Master Formulation Records (MFR) vs. Compounding Records (CR) Requirements & Workflow 10.2 Personnel Training, Core Competency & Written Testing Requirements 10.3 Gloved Fingertip and Thumb Sampling (GFT) Testing Cadence, Pass/Fail Thresholds & Action Plans 10.4 Media-Fill Testing Protocols: Simulation Design, Incubation Parameters & Failure Investigations 10.5 Standard Operating Procedures & Document Control 10.6 Quality Assurance & Quality Control Programs 10.7 Inspection Methods, Self-Audits & Continuous Readiness 10.8 Literature Evaluation: Research Methods, Statistics & Stability Evidence
11 Chapter 11: Regulatory Oversight, Accreditation & Drug Supply Chain
11.1 Drug Quality and Security Act (DQSA) & FDA Section 503A Traditional Pharmacies vs. Section 503B Outsourcing Facilities 11.2 State Boards of Pharmacy, FDA Guidance & Inter-Agency Regulatory Jurisdictions 11.3 Drug Supply Chain Security Act (DSCSA), Component Qualification & Certificate of Analysis (CoA) Verification 11.4 CMS, The Joint Commission, CDC, ASPEN & ASHP: Standards Beyond USP and FDA
12 Chapter 12: Safety Management, Investigations, Recalls & Waste
12.1 Root Cause Analysis (RCA), CAPA Framework & Out-of-Specification (OOS) Investigations 12.2 Adverse Drug Event Reporting, FDA MedWatch Form 3500 & Product Recall Protocols 12.3 Occupational Safety, Hazardous Waste Disposal (RCRA / EPA) & Spill Clean-up Management
9.7 Interprofessional Care Coordination for Sterile Preparations
Key Takeaways Explain This Topic AI
Safe sterile therapy depends on coordination among prescribers, nurses, technicians, infection preventionists, nutrition support and antimicrobial stewardship teams, oncology, facilities, supply chain and informatics.
Standardized concentrations, such as ASHP's Standardize 4 Safety national standards, adopted through the P&T committee and matched in smart-pump libraries, cut errors at every handoff.
CMS Conditions of Participation (42 CFR 482.42) require hospitals to run an antibiotic stewardship program, and pharmacists supply dose, duration and IV-to-oral data for it.
Moving a patient to home infusion requires confirmed vascular access, the first-dose plan, laboratory monitoring orders, insurance approval, and handoffs to the home infusion pharmacy and nursing agency, all arranged before discharge.
Structured communication (SBAR, closed-loop confirmation, huddles) and shared data, such as environmental monitoring trends with infection prevention, turn individual expertise into team reliability.
Last updated: September 2026
9.7 Interprofessional Care Coordination for Sterile Preparations
No compounding pharmacist works alone. A CSP passes through a prescriber's order, a pharmacist's verification, a technician's hands, a delivery system, a nurse's pump and a patient's vein, and then back through monitoring. The BCSCP outline lists interprofessional care coordination (task 2A4) because most serious CSP errors happen at handoffs between people and teams.
The teams and what each needs from sterile compounding
Partner Shared responsibilities What the BCSCP brings
Prescribers and order-set committees Order clarity, standard doses and concentrations Compatibility and stability data; standardized order sets
Nursing Administration, smart pumps, line care Pump-library concentrations, administration instructions, BUD and storage labeling
Pharmacy technicians Compounding and cleaning Training, competency, SOPs and supervision as designated person
Nutrition support team PN prescribing and monitoring (ASPEN) Macronutrient and electrolyte limits, calcium-phosphate solubility, refeeding plans
Antimicrobial stewardship Right drug, dose and duration Dose optimization, extended infusions, IV-to-oral conversion, OPAT stability data
Oncology Chemotherapy regimens and safety Independent dose verification, USP <800> handling, CSTD use at administration
Anesthesia and perioperative services Syringe preparation, OR medication safety Prefilled syringes, immediate-use CSP rules, labeling
Infection prevention CLABSI surveillance, outbreak response Environmental and personnel monitoring data, product-related infection investigations
Facilities and engineering HVAC, pressure, water, power Pressure and temperature specifications; contingency plans (see 2.7)
- Environmental services Cleaning outside the PEC Agents, frequencies, training (see 2.6)
- Supply chain Shortages and substitutions Suitability checks for alternative products and supplies
Informatics IV workflow systems, EHR and pump integration Workflow design, electronic compounding record requirements
- Quality and risk management Error reporting, root cause analysis, recalls Investigations and CAPA (see 12.1)
- Aligning practice across disciplines
P&T committee: Approves formulary products, standard concentrations and protocols so that orders, labels, pump libraries and compounding recipes match.
Standardize 4 Safety: ASHP's initiative publishes national standard concentrations for adult and pediatric continuous infusions and compounded oral liquids. Adopting them reduces confusion when patients move between facilities.
Oncology safety standards: The ASCO/ONS antineoplastic therapy administration safety standards call for independent verification of chemotherapy orders by two qualified practitioners before preparation, and again at administration.
Antimicrobial stewardship: The CMS hospital Conditions of Participation (42 CFR 482.42) require an antibiotic stewardship program alongside infection prevention. Pharmacists typically lead day-to-day review.
Transitions: hospital to home infusion
Loading diagram...
Common failure points include:
- a first dose scheduled for home before any dose has been tolerated in a monitored setting;
- laboratory orders with no named clinician to review the results;
- a device or concentration that differs between hospital and home;
missing stability data for the home delivery interval.
The IDSA's OPAT practice guideline covers patient selection, monitoring and team roles for outpatient antimicrobial therapy.
Communication tools
SBAR (Situation, Background, Assessment, Recommendation) for pharmacist-to-prescriber calls about a CSP problem.
Closed-loop communication: The receiver repeats the key details back (drug, dose, concentration, route), and the sender confirms.
Daily huddles in the IV room, and shared dashboards for turnaround, environmental excursions and shortages.
Written handoffs for shift changes and for patients moving between settings, listing active infusions, concentrations and BUDs.
Data sharing that improves outcomes
Share environmental monitoring and personnel competency trends with infection prevention, so that CLABSI clusters can be reviewed alongside compounding data.
Share near misses caught by workflow technology (wrong vial, wrong diluent) with the medication safety committee, to redesign storage, look-alike labeling or order sets.
Share shortage status early with prescribers and nurses, with alternatives and conversion guidance already prepared.
Coordinating around shortages, recalls and protocols
Shortages: A shortage team of pharmacy, prescribers, nursing and supply chain agrees on substitutes, concentration changes and conservation rules. It then updates order sets, pump libraries and compounding recipes together, so that no single step is left behind.
Recalls and quality alerts: When a CSP or a component is recalled, the pharmacy tells the units, removes stock, identifies patients who received the product, and works with prescribers on monitoring (see 12.2). Infection prevention joins when contamination is possible.
Protocols and collaborative practice: Where state law and the medical staff allow, pharmacists manage parenteral nutrition, aminoglycoside and vancomycin dosing, and electrolyte replacement under approved protocols. They order laboratory tests and adjust therapy within set limits, and they document their communication with the team.
Pharmacy technicians: Certified technicians (for example with a compounded sterile preparation technician credential) are core team members. Clear delegation, competency records and escalation paths let pharmacists focus on verification and clinical review.